Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/06/1989 | US4837223 (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide compositions |
06/06/1989 | US4837222 Xenocoumacins |
06/06/1989 | US4837221 Administering porphyrin derivative to locate tumor, illuminating with light |
06/06/1989 | US4837219 Choline, zinc compound, copper compound, amino acids/ |
06/06/1989 | US4837218 Alkylated bicycloalkaneamines for treatment of neurotoxic injury |
06/06/1989 | US4837216 Applying a triazinetrione compounds |
06/06/1989 | US4837215 Penem derivatives |
06/06/1989 | US4837212 Modulates immune system |
06/06/1989 | US4837211 Spironolactone composition |
06/06/1989 | US4837207 Diastereoisomers of n6 -endo-bicyclo[2.2.1]heptyladenosine as antihypertensives with selective action |
06/06/1989 | US4837206 Esperamicin derivatives |
06/06/1989 | US4837205 Prodrugs of antihypercholesterolemic compounds |
06/06/1989 | US4837149 Fermentation of streptomyces with specific amino acids, adding cyanide salt |
06/06/1989 | US4837111 Dosage form for dispensing drug for human therapy |
06/06/1989 | US4837032 Theophylline sustained release tablet |
06/06/1989 | US4837031 Compositions containing ibuprofen |
06/06/1989 | US4837030 Novel controlled release formulations of tetracycline compounds |
06/06/1989 | US4837029 Dimethyl polysiloxane, cationic or nonionic surfactant |
06/06/1989 | US4837023 Compositions containing hexadecylophosphocholine and alkylglycerols and uses thereof |
06/06/1989 | US4837015 Alkali metal ion-charged, cation exchanger and use thereof to adjust sodium, potassium and calcium body fluid levels |
06/06/1989 | US4837014 With fibrinolytic enzymes and ethylene oxide-propylene oxide c opolymer surfactant |
06/06/1989 | US4836987 Interior coating of lignan derivative |
06/06/1989 | US4836957 Using amino acid |
06/06/1989 | CA1255329A1 Benzoic acid derivatives |
06/06/1989 | CA1255316A2 3-arylcarbonyl-1h-indoles useful as anti-rheumatic agents as well as intermediates and their production process |
06/06/1989 | CA1255315A1 Pyrrolizidine derivative |
06/06/1989 | CA1255314A1 2-(pyrid-2-yl)-methylthio(or methylsulfinyl) benzimidazole derivatives and their production |
06/06/1989 | CA1255313A1 Piperazines derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient |
06/06/1989 | CA1255312A2 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1- substituted alkyl-1h-indoles useful as intermediates for producing analgesic anti-rheumatic and anti- inflammatory agents |
06/06/1989 | CA1255311A1 Isoindolinyl-alkyl-piperazines |
06/06/1989 | CA1255310A1 4-phenyloxyalkyl-1,2,4-triazol-3-one antidepressants |
06/06/1989 | CA1255306A1 Octahydro-indolizine compounds useful as analgesics |
06/06/1989 | CA1255304A1 Tetracyclic spiro-hydantoin aldose reductase inhibitors |
06/06/1989 | CA1255301A1 Process and intermediates for the preparation of aryl substituted pyrido¬1,4|benzodiazepines |
06/06/1989 | CA1255300A1 Method of inducing immunosuppression |
06/06/1989 | CA1255299A1 Guanidinothiazole derivatives containing alkylene bridges, a process for their preparation and their use as medicaments |
06/06/1989 | CA1255296A1 ¬16,17-a|cyclopentano pregnenes |
06/06/1989 | CA1255295A1 Substituted benzoate ester prodrugs of estrogens |
06/06/1989 | CA1255231A1 Anti-tumour pharmaceutical composition and process for preparing the same |
06/06/1989 | CA1255230A1 Pharmaceutical composition containing podophyllotoxin or a derivative thereof |
06/06/1989 | CA1255229A1 Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine |
06/06/1989 | CA1255228A1 Azolylmethylcycloalkanes, their preparation and their use as drugs |
06/06/1989 | CA1255227A1 Method for production of stable nicorandil preparation |
06/06/1989 | CA1255223A1 Pellet formulation |
06/06/1989 | CA1255175A1 Self-adhesive plaster |
06/01/1989 | WO1989004833A1 Renin inhibiting peptides that contain amino and hydroxy dicarboxylic acids |
06/01/1989 | WO1989004830A1 New substituted derivatives of 20,21-dinoreburnamenine, process for preparing them and the new intermediate products so obtained, their application as drugs and the pharmaceutical compositions containing them |
06/01/1989 | WO1989004829A1 Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
06/01/1989 | WO1989004828A1 Cyclodextrin clathrates of 5-cyano-prostacycline derivatives and their use as drugs |
06/01/1989 | WO1989004827A1 Process for the synthesis of 3-thio-4-quinolone derivatives and intermediate compounds for use therein, and their use as medicaments |
06/01/1989 | WO1989004825A1 New derivatives of cysteine, processes for their preparation and their use |
06/01/1989 | WO1989004821A1 N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents |
06/01/1989 | WO1989004820A1 Amino-4 trifluoromethyl-1 tetraline derivatives, their preparation and therapeutic application |
06/01/1989 | WO1989004673A1 Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained |
06/01/1989 | WO1989004671A1 Differential delivery of therapeutic agents across the blood brain barrier |
06/01/1989 | WO1989004662A1 Adenosine deaminase-stable anti-retroviral nucleosides |
06/01/1989 | WO1989004661A1 Nicotine compositions |
06/01/1989 | WO1989004660A1 5-ht3 receptor antagonists for treatment of cough and bronchoconstriction |
06/01/1989 | WO1989004659A1 Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging |
06/01/1989 | WO1989004658A1 Onset-hastened/enhanced analgesia using s(+) ketoprofen |
06/01/1989 | WO1989004656A1 Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
06/01/1989 | WO1989004651A1 Composition based on hydrated lipid lamellar phases or liposomes containing tyrosine or a tyrosine derivative and cosmetic or pharmaceutical composition, in particular dermatological composition, with pigmenting activity, containing it |
06/01/1989 | DE3839401A1 N-heterocyclische alkohol-derivate N-heterocyclic alcohol derivatives |
06/01/1989 | DE3835962A1 Polyisodiaminocarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel und pflanzenschutzmittel Polyisodiaminocarbonsaeuren, process for their production and those containing medicinal and plant protection products |
05/31/1989 | EP0318464A2 Antitumor platinum complexes |
05/31/1989 | EP0318446A1 Amino acid composition for parenteral nutritional support |
05/31/1989 | EP0318398A1 Diltiazem sustained release form and medicament thereof |
05/31/1989 | EP0318392A1 N-(vinblastinoyl-23)derivatives of 1-amino methylphosphonic acids, processes for their preparation and pharmaceutical compositions containing them |
05/31/1989 | EP0318385A1 Therapeutic transdermal device and its process of preparation |
05/31/1989 | EP0318377A2 Enantiomeric derivatives of amino acids, process for their preparation and their pharmaceutical applications |
05/31/1989 | EP0318369A1 Hydrated lipidic lamellar composition or liposome containing tyrosine or tyrosine derivative and cosmetic or pharmaceutical topical tanning composition thereof |
05/31/1989 | EP0318357A2 1,3-Butanediol acetoacetate and its use in parenteral and oral nutrition |
05/31/1989 | EP0318281A2 Use of dsRNA in the prevention of viral escape |
05/31/1989 | EP0318235A2 PAF antagonist, 1,4-disubstituted piperazine compounds and production thereof |
05/31/1989 | EP0318234A2 Improvements in or relating to selective serotonin uptake inhibitors |
05/31/1989 | EP0318233A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors |
05/31/1989 | EP0318225A2 6-Aryl aminomethyl quinoline derivatives and their use as anti-tumour agents |
05/31/1989 | EP0318214A1 Tri- and tetra-substituted-oxetanes and -tetrahydrofurans and intermediates thereof |
05/31/1989 | EP0318211A1 Nedocromil sodium compositions and methods for their preparation |
05/31/1989 | EP0318184A1 Acceleration of bone formation with GM-CSF |
05/31/1989 | EP0318181A2 N-(Biphenylmethyl)-3-hydroxyglutaramic acids and derivatives as hypocholesterolemic agents |
05/31/1989 | EP0318166A2 Isoxazolo[4,5-c]azepine derivatives, process for their preparation and pharmaceutical compositions containing them |
05/31/1989 | EP0318146A1 Antibiotic solutions and the lyophilization thereof |
05/31/1989 | EP0318093A2 Diarylquinoline diacids and their use as medicaments |
05/31/1989 | EP0318092A2 Novel beta-adrenergic agonists |
05/31/1989 | EP0318091A2 Resolved amino pyrrolidine neuroprotective agents |
05/31/1989 | EP0318090A2 Tert-butyl phenyl compounds as anti-inflammatory agents |
05/31/1989 | EP0318085A2 Heterazole dialkanoic acids |
05/31/1989 | EP0318084A2 Benzoheterazoles |
05/31/1989 | EP0318083A2 Pyridyl dialkanoic acids and their use as medicaments |
05/31/1989 | EP0318066A1 Aryl-substituted thiophene 3-ols, derivatives and analogs, as lipoxygenase inhibitors |
05/31/1989 | EP0318029A2 Cyclic amine and pharmacological composition |
05/31/1989 | EP0317997A2 1,4-Disubstituted-piperidinyl compounds |
05/31/1989 | EP0317991A2 1-Aryl-3-quinoline- and 1-aryl-3-isoquinoline-carboxamides, a process for their preparation and their use as medicaments |
05/31/1989 | EP0317959A2 Anti-ulcer composition |
05/31/1989 | EP0317956A2 Anti-tumor prodrugs |
05/31/1989 | EP0317953A2 N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury |
05/31/1989 | EP0317933A2 Treatment of fibromyalgia |
05/31/1989 | EP0317855A2 Pharmaceutical products |
05/31/1989 | EP0317846A1 Pharmaceutical and cosmetical compositions based on benzoyl peroxide and lipophilic quaternary ammonium salicylates and their use, in particular in treating acne |